OPKO Health, Inc. (TLV:OPK)

Market Cap	3.40B
Revenue (ttm)	2.13B
Net Income (ttm)	-597.31M
Shares Out	n/a
EPS (ttm)	-0.82
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	283,575
Average Volume	752,947
Open	436.30
Previous Close	438.80
Day's Range	426.70 - 438.80
52-Week Range	402.00 - 734.40
Beta	1.34
RSI	42.11
Earnings Date	Feb 27, 2026

About OPKO Health

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company’s Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare to physician offices, clinics, hospitals, employers, ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2007
• Employees: 2,997
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: OPK

Financial Performance

In 2024, OPKO Health's revenue was $713.14 million, a decrease of -17.41% compared to the previous year's $863.50 million. Losses were -$53.22 million, -71.82% less than in 2023.

Financial numbers in USD